...Chunyan Lei; Yongyu Li; Xianlian Zhou; Shihan Lin; Xiaoyan Zhu; Xinglong Yang; Chun Chen Introduction: Hemorrhagic transformation, especially symptomatic intracranial hemorrhage (sICH), is a common complication after mechanical embolectomy. This study explored a grading scale based on clinical...

...Shuyang Dong; Chuanqing Yu; Qingbin Wu; Henglei Xia; Jialong Xu; Kun Gong; Tao Wang Introduction: This meta-analysis assessed the predictors of symptomatic intracranial hemorrhage (sICH) after endovascular thrombectomy (EVT) for patients with acute ischemic stroke. Methods: PubMed, Embase...

...Jose María Cabrera-Maqueda; Maria Teresa Alba-Isasi; Jose Díaz-Pérez; Laura Albert-Lacal; Ana Morales; Guillermo Parrilla Background: Comparison of symptomatic intracranial hemorrhage (SICH) rates between stroke patients treated with bridging therapy (BT) and primary mechanical thrombectomy (PMT...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Superficial siderosis Intravenous thrombolysis Ischemic stroke Symptomatic intracranial hemorrhage Cerebral amyloid angiopathy Intravenous thrombolysis (IVT) with alteplase...

... by the National Institutes of Health Stroke Scale. Safety was assessed by rates of symptomatic intracranial hemorrhage (SICH), brain edema with mass effect and 7-day mortality. Outcome was assessed at 3 months as mortality and proportion of independent patients (modified Rankin Scale score between 0 and 2...

...Raymond C.S. Seet; Alejandro A. Rabinstein Background: Symptomatic intracranial hemorrhage (SICH) is a devastating complication of intravenous thrombolysis treatment that is associated with high mortality. Clinical trials, stroke registries and cohort studies employ different case definitions...

... with acute proximal intracranial arterial occlusions enrolled in randomized clinical trials of sonothrombolysis [ 4,5 ]. Symptomatic intracranial hemorrhage (sICH) is the most unfavorable and feared complication of intravenous thrombolysis and the most important factor deterring the use of intravenous...

... cohort study with patient enrollment from 60 centres across Canada over 2.5 years. The 90-day outcome, mortality and symptomatic intracranial hemorrhage of patients thrombolysed between 3 and 4.5 h and within 3 h of symptom onset were compared. A mRS 0–1 (no symptoms at all or no significant disability...